Protein S-Nitrosylation Controls Glycogen Synthase Kinase 3&bgr; Function Independent of Its Phosphorylation State

Rationale: GSK-3&bgr; (glycogen synthase kinase 3&bgr;) is a multifunctional and constitutively active kinase known to regulate a myriad of cellular processes. The primary mechanism to regulate its function is through phosphorylation-dependent inhibition at serine-9 residue. Emerging evidence indicates that there may be alternative mechanisms that control GSK-3&bgr; for certain functions. Objectives: Here, we sought to understand the role of protein S-nitrosylation (SNO) on the function of GSK-3&bgr;. SNO-dependent modulation of the localization of GSK-3&bgr; and its ability to phosphorylate downstream targets was investigated in vitro, and the network of proteins differentially impacted by phospho- or SNO-dependent GSK-3&bgr; regulation and in vivo SNO modification of key signaling kinases during the development of heart failure was also studied. Methods and Results: We found that GSK-3&bgr; undergoes site-specific SNO both in vitro, in HEK293 cells, H9C2 myoblasts, and primary neonatal rat ventricular myocytes, as well as in vivo, in hearts from an animal model of heart failure and sudden cardiac death. S-nitrosylation of GSK-3&bgr; significantly inhibits its kinase activity independent of the canonical phospho-inhibition pathway. S-nitrosylation of GSK-3&bgr; promotes its nuclear translocation and access to novel downstream phosphosubstrates which are enriched for a novel amino acid consensus sequence motif. Quantitative phosphoproteomics pathway analysis reveals that nuclear GSK-3&bgr; plays a central role in cell cycle control, RNA splicing, and DNA damage response. Conclusions: The results indicate that SNO has a differential effect on the location and activity of GSK-3&bgr; in the cytoplasm versus the nucleus. SNO modification of GSK-3&bgr; occurs in vivo and could contribute to the pathobiology of heart failure and sudden cardiac death.

[1]  Laurence H. Pearl,et al.  Crystal Structure of Glycogen Synthase Kinase 3β Structural Basis for Phosphate-Primed Substrate Specificity and Autoinhibition , 2001, Cell.

[2]  R. Jope,et al.  The multifaceted roles of glycogen synthase kinase 3β in cellular signaling , 2001, Progress in Neurobiology.

[3]  Eriko Tokunaga,et al.  S-Nitrosylation-dependent Inactivation of Akt/Protein Kinase B in Insulin Resistance* , 2005, Journal of Biological Chemistry.

[4]  U. Walter,et al.  Physiology and pathophysiology of vascular signaling controlled by guanosine 3',5'-cyclic monophosphate-dependent protein kinase. , 2004, Acta biochimica Polonica.

[5]  E. Olson,et al.  Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore , 2004 .

[6]  Michel Goedert,et al.  GSK3 inhibitors: development and therapeutic potential , 2004, Nature Reviews Drug Discovery.

[7]  T. Lincoln,et al.  Activation of Mitogen-activated Protein Kinase Pathways by Cyclic GMP and Cyclic GMP-dependent Protein Kinase in Contractile Vascular Smooth Muscle Cells* , 1999, The Journal of Biological Chemistry.

[8]  J. Downey,et al.  Preconditioning the myocardium: from cellular physiology to clinical cardiology. , 2003, Physiological reviews.

[9]  Jun Qin,et al.  Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin , 2005 .

[10]  D. Alessi,et al.  The role that inactivation of GSK 3 isoforms resulting from Ser 9 / Ser 21 phosphorylation plays in insulin-signalling and Wnt-mediated-catenin stabilisation defined by knockin analysis , 2005 .

[11]  Jun Qin,et al.  Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. , 2005, Molecular cell.

[12]  M. Alda.  LITHIUM IN THE TREATMENT OF BIPOLAR DISORDER: PHARMACOLOGY AND PHARMACOGENETICS , 2015, Molecular Psychiatry.

[13]  J. Woodgett,et al.  Loss of Adult Cardiac Myocyte GSK-3 Leads to Mitotic Catastrophe Resulting in Fatal Dilated Cardiomyopathy. , 2016, Circulation research.

[14]  Leonardo Nogueira,et al.  Proteomic analysis of S-nitrosylation and denitrosylation by resin-assisted capture , 2009, Nature Biotechnology.

[15]  Ping-Ho Chen,et al.  Camptothecin promotes the production of nitric oxide that triggers subsequent S-nitrosoproteome-mediated signaling cascades in endothelial cells. , 2017, Vascular pharmacology.

[16]  E. Olson,et al.  Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Borthwick,et al.  The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro , 2011, In Vitro Cellular & Developmental Biology - Animal.

[18]  Brian O'Rourke,et al.  Redox Regulation of Mitochondrial ATP Synthase: Implications for Cardiac Resynchronization Therapy , 2011, Circulation Research.

[19]  S. Sollott,et al.  Role of Glycogen Synthase Kinase-3β in Cardioprotection , 2009, Circulation research.

[20]  K. Lynch,et al.  Phosphorylation-dependent regulation of PSF by GSK3 controls CD45 alternative splicing. , 2010, Molecular cell.

[21]  Trey Ideker,et al.  Cytoscape 2.8: new features for data integration and network visualization , 2010, Bioinform..

[22]  D. Kass,et al.  Cardiac resynchronization sensitizes the sarcomere to calcium by reactivating GSK-3β. , 2014, The Journal of clinical investigation.

[23]  F. Hofmann,et al.  Physiology and pathophysiology of vascular signaling controlled by guanosine 3',5'-cyclic monophosphate-dependent protein kinase [corrected]. , 2003, Circulation.

[24]  M. Roussel,et al.  Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. , 1998, Genes & development.

[25]  E. Appella,et al.  GSK-3 beta targets Cdc25A for ubiquitin-mediated proteolysis, and GSK-3 beta inactivation correlates with Cdc25A overproduction in human cancers. , 2008, Cancer cell.

[26]  C. Sutherland.  What Are the bona fide GSK3 Substrates? , 2011, International journal of Alzheimer's disease.

[27]  Tingzhe Sun,et al.  S-nitrosylation of ERK inhibits ERK phosphorylation and induces apoptosis , 2013, Scientific Reports.

[28]  Milan Surjit,et al.  Glycogen Synthase Kinase - 3 Phosphorylates and Regulates the Stability of p27kip1 Protein , 2007, Cell cycle.

[29]  S. Dalton,et al.  Subcellular Localization of Glycogen Synthase Kinase 3β Controls Embryonic Stem Cell Self-Renewal , 2009, Molecular and Cellular Biology.

[30]  Matko Bosnjak,et al.  REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms , 2011, PloS one.

[31]  Gustavo Pedraza-Alva,et al.  Phosphorylation by p38 MAPK as an Alternative Pathway for GSK3β Inactivation , 2008, Science.

[32]  H. E. Marshall,et al.  Protein S-nitrosylation: purview and parameters , 2005, Nature Reviews Molecular Cell Biology.

[33]  R. Jope,et al.  Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. , 2015, Pharmacology & therapeutics.

[34]  J. Woodgett,et al.  Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy , 2000, The Journal of cell biology.

[35]  J. Balligand,et al.  Nitric Oxide and Cardiac Function: Ten Years After, and Continuing , 2003, Circulation research.

[36]  P. Cohen,et al.  The renaissance of GSK3 , 2001, Nature Reviews Molecular Cell Biology.

[37]  G. Schafe,et al.  Synaptic plasticity and NO-cGMP-PKG signaling coordinately regulate ERK-driven gene expression in the lateral amygdala and in the auditory thalamus following Pavlovian fear conditioning. , 2010, Learning & memory.

[38]  G. Gross.  The role of mitochondrial KATP channels in cardioprotection , 2000, Basic Research in Cardiology.

[39]  J. Lucas,et al.  Glycogen Synthase Kinase-3 Plays a Crucial Role in Tau Exon 10 Splicing and Intranuclear Distribution of SC35 , 2004, Journal of Biological Chemistry.

[40]  J. Woodgett,et al.  The GSK-3 family as therapeutic target for myocardial diseases. , 2015, Circulation research.

[41]  R. Jope,et al.  Resolution of the Nuclear Localization Mechanism of Glycogen Synthase Kinase-3 , 2007, Journal of Biological Chemistry.

[42]  Solomon H. Snyder,et al.  The Biotin Switch Method for the Detection of S-Nitrosylated Proteins , 2001, Science's STKE.

[43]  P. Cohen,et al.  The selectivity of protein kinase inhibitors: a further update. , 2007, The Biochemical journal.

[44]  Christopher I. Murray,et al.  Site-Mapping of In Vitro S-nitrosation in Cardiac Mitochondria: Implications for Cardioprotection* , 2010, Molecular & Cellular Proteomics.

[45]  A. Zeiher,et al.  Glycogen Synthase Kinase-3 Couples AKT-dependent Signaling to the Regulation of p21Cip1 Degradation* , 2002, The Journal of Biological Chemistry.

[46]  E. Olson,et al.  Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Vidya Venkatraman,et al.  Cysteine oxidative posttranslational modifications: emerging regulation in the cardiovascular system. , 2013, Circulation research.

[48]  J. Peters,et al.  The cohesin complex and its roles in chromosome biology. , 2008, Genes & development.

[49]  T. Abraham,et al.  Inhibiting Mitochondrial Na+/Ca2+ Exchange Prevents Sudden Death in a Guinea Pig Model of Heart Failure , 2014, Circulation research.

[50]  Bin Zhang,et al.  PhosphoSitePlus, 2014: mutations, PTMs and recalibrations , 2014, Nucleic Acids Res..

[51]  P. Cohen,et al.  Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. , 1993, The Biochemical journal.

[52]  Guanming Wu,et al.  A network module-based method for identifying cancer prognostic signatures , 2012, Genome Biology.

[53]  R. Hajjar,et al.  Differential Activation of Signal Transduction Pathways in Human Hearts With Hypertrophy Versus Advanced Heart Failure , 2001, Circulation.

[54]  James Robert Woodgett,et al.  Molecular Neuroscience Review Article Gsk-3: Functional Insights from Cell Biology and Animal Models , 2022 .

[55]  Ana Martínez,et al.  GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS , 2011, Front. Mol. Neurosci..

[56]  Martin Kuiper,et al.  BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological Networks , 2005, Bioinform..

[57]  M. Kastan,et al.  Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage. , 2002, Genes & development.

[58]  Robert J Chalkley,et al.  Glucose sensor O-GlcNAcylation coordinates with phosphorylation to regulate circadian clock. , 2013, Cell metabolism.

[59]  Nichole L. King,et al.  The PeptideAtlas Project , 2010, Proteome Bioinformatics.

[60]  Guang Tong,et al.  Essential role of nitric oxide in acute ischemic preconditioning: S-nitros(yl)ation versus sGC/cGMP/PKG signaling? , 2013, Free radical biology & medicine.

[61]  P. Cohen,et al.  Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.

[62]  R. Jope,et al.  Proapoptotic Stimuli Induce Nuclear Accumulation of Glycogen Synthase Kinase-3β* , 2001, The Journal of Biological Chemistry.